4.7 Article

Selective effects of Euterpe oleracea (acai) on Leishmania (Leishmania) amazonensis and Leishmania infantum

Journal

BIOMEDICINE & PHARMACOTHERAPY
Volume 97, Issue -, Pages 1613-1621

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2017.11.089

Keywords

American visceral leishmaniasis; American cutaneous leishmaniasis; Euterpe oleracea; Leishmania death; Acai

Funding

  1. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [424820/2016-1]
  2. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
  3. PROPESP-UFPA
  4. Instituto Nacional de Biologia Estrutural e Bioimagem-INBEB (CNPq) [573767/2008-4]

Ask authors/readers for more resources

Leishmania (Leishmania) amazonensis and Leishmania infantum (= Leishmania chagasi) are protozoa that cause American cutaneous and visceral leishmaniasis, respectively. These diseases show a high incidence in developing countries such as Brazil. The treatments used for leishmaniasis are still limited due to their high cost and toxicity. Currently, some natural products are considered an important alternative source of new leishmanicidal agents. Euterpe oleracea Martius, a palm producing black fruits, is frequently consumed in the Amazon region, as a juice, known as acai, with potent antioxidant, anti-inflammatory and anticonvulsant properties. Interestingly, the biological activity of clarified acai juice (EO) on L. (L.) amazonensis and L. infantum (= L. chagasi) is unknown. Therefore, the mechanism of anti-leishmanial action of EO has been evaluated on L. (L.) amazonensis and L. infantum (= L. chagasi). EO reduced the number of promastigotes and caused morphological alterations, increased the production of reactive oxygen species (ROS) and induced cell death phenotypes probably seems by apoptosis in the promastigotes of L. (L.) amazonensis (IC50 = 1: 40) and L. infantum (= L. chagasi) (IC50 = 1: 38). EO also presented activity against Leishmania amastigotes. Treatment with EO for 72 h strongly reduced IL-17 cytokine levels at all tested concentrations and decreased the number of intracellular amastigotes in macrophages infected with L. (L.) amazonensis (IC50 = 1: 30) and L. infantum (= L. chagasi) (IC50 = 1: 38). Additionally, no cytotoxic effect was observed in murine macrophages treated with EO (72 CC50 > 1: 1). Our results demonstrated that EO has leishmanicidal activity against two different species that cause American visceral and cutaneous leishmaniasis without cytotoxic effects for the host cell.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available